News
Measles, scarlet fever among infectious diseases to watch for in 2020
ORLANDO – In 2019, data on the safety and effectiveness of the recombinant herpes zoster vaccine in immunocompromised patients became available....
News
Systemic therapy options for pediatric skin diseases are improving
ORLANDO – Some systemic therapies are off label “but used all the time” for dermatologic diseases in pediatrics.
News
Be ready for patient questions on sunscreen safety, SPF choice
ORLANDO – Which SPF to choose and the impact of sunscreen on vitamin D are among the issues patients may be asking about.
News
Dermatologists are uniquely suited to help sexual-, gender-minority patients
ORLANDO – Dr. Landriscina encouraged attendees to take the information they learned in the session and “run with it.”
News
Adult survivors of childhood cancer are experiencing fewer major cardiac events
Reduced radiation exposure is a likely contributor to the improved cardiovascular outcomes.
News
Adolescent alcohol, opioid misuse linked to risky behaviors
Binge drinking in high school may predict risky driving behaviors for years after graduation.
News
Dual e-cigarette and combustible tobacco use compound respiratory disease risk
E-cigarettes have been promoted as a safer alternative to combustible tobacco.
News
Well-tolerated topical capsaicin formulation reduces knee OA pain
ATLANTA – A new vehicle formulation improves tolerability of capsaicin treatment.
News
ACR and EULAR release first classification criteria for IgG4-related disease
In two validation cohorts, the criteria had specificities of 97.8%-99.2% and sensitivities of 82.0%-85.5%.
News
VEDOSS study describes predictors of progression to systemic sclerosis
ATLANTA – When Raynaud’s phenomenon is present, risk for progression is best predicted by the presence of puffy fingers, disease-specific...
News
Tofacitinib improves disease activity in patients with polyarticular-course JIA
ATLANTA – The phase 3 trial looked at flare rate out to 44 weeks after patients first met response criteria following 18 weeks of open-label...
News
Repeat LTBI testing best in patients taking biologics with new risk factors
ATLANTA – Just 1.2% of patients taking biologics with negative tuberculosis test results converted to positive results in annual tuberculosis...
News
Lp(a) molar concentration flags CVD, diabetes risk
Higher lipoprotein(a) molar concentration is linked to an increased risk of cardiovascular disease, compared with apolipoprotein(a) size.
News
Perioperative antirheumatic drug use does not impact postsurgery infection rate in RA patients
ATLANTA – A higher Charlson Comorbidity Index and longer surgery time, rather than preop antirheumatic medications, increased risk of infection....
News
Tanezumab posts higher safety event rate than NSAIDs over 1 year in hip, knee OA
ATLANTA – More safety events were seen with the higher 5-mg dose than with 2.5 mg.